Press releases 9th December 2020

Cycling Athlete Robert Pelegrin Accepts Sanction for ADRV

USADA announced today that Robert Pelegrin, an athlete in the sport of cycling, has accepted a 12-month suspension for an anti-doping rule violation. Pelegrin, 66, tested positive for anastrozole as the result of an in-competition drug test collected on August 30, 2019 at the USA Cycling Masters Track National Championships. He was selected for testing because he won his event. Anastrozole is a Specified Substance in the class of Hormone and Metabolic Modulators and is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the Union Cycliste Internationale Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.

Pelegrin’s 12-month period of ineligibility began on November 9, 2019, the date his provisional suspension was imposed. In addition, Pelegrin has been disqualified from competitive results obtained on and subsequent to July 23, 2015, including forfeiture of any medals, points and prizes.

• This media release was published by the US Anti-Doping Agency (USADA) on 9 December 2020. Click here for the original.

You may also like...

Pin It on Pinterest

Share This